Xavier Cansouline

Dr. Xavier Cansouline


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
XCXavier Cansouline
Xavier Cansouline
AEAbdelhakim Elmraki
Abdelhakim Elmraki
BLBéatrice Lipan
Béatrice Lipan
DSDamien Sizaret
Damien Sizaret
MSMathieu Sordet
Mathieu Sordet
ALAntoine Legras
Antoine Legras
Objective: We explored the impact of uncertain resection in lung cancer on overall survival and disease-free survival. Methods: We performed an exhaustive literature review of all studies comparing prognosis after resection according to the IASLC classification, from the PubMed, Cochrane, MEDLINE, and Google Scholar databases. Results: Overall, 68 original studies were included, of which 67 were retrospective and 1 was prospective, with 81 785 patients included over 46 years. R(un) reclassification was mostly caused by a lack of hilar or mediastinal node dissection, or because of metastasis in the highest node. R(un) is a strong factor for higher recurrence and mortality, while its effects seem limited in early stages. Carcinoma in situ at bronchial margin resection (CIS BRM) does not show an effect on survival, while positive pleural cytology (Cy+) and positive highest mediastinal lymph node (HMLN+) appear to be highly predictive of recurrence and death. Discussion: The R(un) classification of the IASLC appears highly relevant, especially in locally advanced stages IIb-IIIA, and helps to discriminate patients with poor prognosis despite being classified as R0 in the UICC classification. Conclusions: The use of this more precise classification would allow for better stratification of recurrence risk and more effective use of adjuvant therapies. Cy+ patients should receive adjuvant chemotherapy, while CIS BRM patients could likely benefit from endoscopic surveillance to detect local recurrences. HMLN+ patients should be considered at high risk of recurrence, and adjuvant radio-chemotherapy should be considered.

18 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
XCXavier Cansouline
Xavier Cansouline
AEAbdelhakim Elmraki
Abdelhakim Elmraki
BLBéatrice Lipan
Béatrice Lipan
DSDamien Sizaret
Damien Sizaret
SMSordet Mathieu
Sordet Mathieu
ALAntoine Legras
Antoine Legras
Objective: We aimed to explore the relevance of uncertain resection in lung cancer. Methods: We performed an exhaustive literature review of all studies comparing prognosis after resection according to IASLC classification. Results: Systematic review led to select 68 original studies included in this review. R(un) reclassification was mostly caused by a lack of hilar or mediastinal node dissection, or because of metasta-sis in the highest node. R(un) is a strong factor for higher recurrence and mortality, while its effects seem limited in early stages. Carcinoma in situ at bronchial margin resection (CIS BRM) does not show effect on survival, while positive pleural cytology (Cy+) and positive highest mediastinal lymph node (HMLN+) appear to be highly pre-dictive of recurrence and death. Conclusion: The R(un) classification of the IASLC 2005 appears highly relevant, espe-cially in locally advanced stages IIb-IIIA, and helps to discriminate patients with poor prognosis despite being classified as R0 according to UICC classification. The use of this more precise classification would allow for better stratification of recurrence risk and more effective use of adjuvant therapies. Cy+ patients should receive adjuvant chemotherapy, while CIS BRM patients could likely benefit from endoscopic surveil-lance to detect local recurrences. HMLN+ patients should be considered at high risk of recurrence, and adjuvant radiochemotherapy should be considered.

20 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
XCXavier Cansouline
Xavier Cansouline
AGAbdoul-Khadry Gassama
Abdoul-Khadry Gassama
AEAbdelhakim Elmraki
Abdelhakim Elmraki
BLBeatrice Lipan
Beatrice Lipan
DSDamien Sizaret
Damien Sizaret
ALAntoine Legras
Antoine Legras
Introduction: Segmentectomy for non–small cell lung cancer (NSCLC) is increasingly performed for small-sized lesions. However, prognostic factors associated with poor out-comes after this lung-sparing oncologic surgery remain unclear. Methods: We conducted a single-center retrospective study including 100 patients who underwent segmentectomy in real-life practice. Results: Univariate analyses identified compromise segmentectomy (HR 3.52; p = 0.005), complex segmentectomy (HR 2.56; p = 0.02), resection of a lesion with SUVmax > 6 (HR 2.86; p = 0.017), and thoracotomy approach (HR 2.62; p = 0.02) as risk factors for mortality. Regarding recurrence, thoracotomy (HR 2,77; p= 0,04) was a poor prognostic factor. Conclusion: We have identified risk factors for mortality and recurrence after segmentectomy and highlighted the need for improved assessment of the manage-ment of patients candidates for compromise segmentectomies.